National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

About this update from Sonoma Pharmaceuticals, Inc.

[{"type":"text","content":"BOULDER, CO / ACCESS Newswire / August 26, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced that Reliefacyn® Advanced Itch-Burn-Rash-Pain Relief Hydrogel has earned the National Psoriasis Foundation (NPF) Seal of Recognition.","length":503,"tagName":"p"},{"type":"text","content":"The NPF Seal of Recognition is awarded to products that have been independently reviewed and verified by a panel of medical experts. Products awarded the Seal of Recognition have met the NPF's standards for safety, ingredient quality, and tolerability on sensitive skin.","length":274,"tagName":"p"},{"type":"text","content":""We are honored to receive the NPF Seal of Recognition," said Amy Trombly, CEO of Sonoma Pharmaceuticals. "This recognition from the NPF reaffirms the superior efficacy, safety and high standards of our products. We are pleased to offer products like Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel, which has previously received the National Eczema Association Seal of Acceptance, to provide relief to people living with chronic skin conditions like eczema, psoriasis and sensitive skin."","length":517,"tagName":"p"},{"type":"text","content":"About Sonoma Pharmaceuticals, Inc.","length":34,"tagName":"p"},{"type":"text","content":"Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Sonoma's products are clinically proven to reduce itch, pain, scarring, and irritation safely and without damaging healthy tissue. In-vitro and clinical studies of HOCl show it to safely manage skin abrasions, lacerations, minor irritations, cuts, and intact skin. Sonoma's products are sold either directly or via partners in over 55 countries worldwide and the company actively seeks new distribution partners. The company's principal office is in Boulder, Colorado, with manufacturing operations in Guadalajara, Mex...

More updates from Sonoma Pharmaceuticals, Inc.